Galectin-3 Up-Regulation in Hypoxic and Nutrient Deprived Microenvironments Promotes Cell Survival

Characterization ofLGALS3(galectin-3) as a player in DNA damage response

(2014) Renato S Carvalho et al.   CANCER BIOLOGY & THERAPY

The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma

(2014) Marta Celegato et al.   CANCER LETTERS

Galectins and neovascularization in central nervous system tumors

(2014) N. D'Haene et al.   GLYCOBIOLOGY

Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers

(2014) Ramya Lakshminarayan et al.   NATURE CELL BIOLOGY

Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages

(2014) Camila Maria Longo Machado et al.   Cancer Medicine

Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes

(2013) Francesca Rovetta et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis

(2012) Enza Piccolo et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The effect of galectin-3 genetic variants on the susceptibility and prognosis of gliomas in a Chinese population

(2012) Hong-jie Chen et al.   NEUROSCIENCE LETTERS

Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling

(2012) Shumei Song et al.   PLoS One

Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin

(2011) Tsutomu Kobayashi et al.   INTERNATIONAL JOURNAL OF CANCER

Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells

(2011) Anna I. Markowska et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Galectin-3 Facilitates Cell Motility in Gastric Cancer by Up-Regulating Protease-Activated Receptor-1(PAR-1) and Matrix Metalloproteinase-1(MMP-1)

(2011) Seok-Jun Kim et al.   PLoS One

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis

(2010) S Y Nam et al.   BRITISH JOURNAL OF CANCER

c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3

(2010) X Li et al.   CELL DEATH AND DIFFERENTIATION

A Novel Clinically Relevant Animal Model for Studying Galectin-3 and Its Ligands During Colon Carcinogenesis

(2010) Marcelo Hill et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Mechanism of Hypoxia-Induced NF- B

(2010) C. Culver et al.   MOLECULAR AND CELLULAR BIOLOGY

CoCl2Induces Apoptosis via the 18 kDa Translocator Protein in U118MG Human Glioblastoma Cells

(2009) Sivan Zeno et al.   BIOCHEMISTRY

Galectins and Gliomas

(2009) Marie Le Mercier et al.   BRAIN PATHOLOGY

Regulation of hypoxia-inducible factor-1α by NF-κB

(2008) Patrick van Uden et al.   BIOCHEMICAL JOURNAL

Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro

(2008) Camila ML Machado et al.   BMC CANCER

Sialylation of β1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced Apoptosis

(2008) Ya Zhuo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Runx2 is expressed in human glioma cells and mediates the expression of galectin-3

(2008) Valentina Vladimirova et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Expression of galectin-3 in the tumor immune response in colon cancer

(2008) Patrick Dumont et al.   LABORATORY INVESTIGATION